< Back to previous page
Patent
Alkylated haloquinolines for use in epilepsy
The invention relates to alkylated haloquinolines for use in the prevention or treatment of a seizure in epilepsy or in neuroinflammation associated with epilepsy.
Patent Publication Number: WO2023041657
Year filing: 2022
Year approval: 2024
Year publication: 2023
Status: Requested
URI: link to Espacenet
Technology domains: Pharmaceuticals
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven